Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.
Robinson
G S
GS
Hybridon, Inc., Cambridge, MA 02139, USA.
Aiello
L P
LP
D000328:Adult; D000368:Aged; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000209:etiology / Q000378:metabolism* / Q000628:therapy; D018450:Disease Progression; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D007223:Infant; D016023:Integrins / Q000378:metabolism; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000378:metabolism* / Q000628:therapy; D012171:Retinal Vessels / Q000378:metabolism
D006133:Growth Substances; D016023:Integrins